SPECT/CT Performance Comparison Using StarGuide GX in Adults
Official title: Demonstration of the StarGuide GX SPECT/CT System
Run by GE Healthcare · NCT07725237 · Data updated 2026-11-12
This study tests whether the StarGuide GX SPECT/CT scan matches the results of a patient’s clinically indicated SPECT/CT in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | GE Healthcare Industry-sponsored |
| Locations | 1 site (Haifa) |
| Status | Recruiting |
| Started | July 20, 2026 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT07725237 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who have a clinically indicated SPECT/CT exam scheduled and can provide informed consent.
✕Probably not a fit
Patients without a comparable or interpretable baseline SPECT/CT may not benefit from additional imaging data.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this observational study, adults undergoing a clinically indicated SPECT/CT will receive an additional StarGuide GX SPECT/CT scan. The imaging data from StarGuide GX will be compared to the participant’s standard SPECT/CT results to evaluate concordance. The study aims to collect image data in a real clinical setting to assess the StarGuide GX system’s performance. Participation is limited to those who can consent and have an appropriate clinical scan scheduled. GE Healthcare leads the trial with Rambam Health Care Campus as a collaborating site.
Why it matters
Potential benefit: If successful, the StarGuide GX system may provide reliable imaging data that could influence future clinical imaging practices.
How similar studies have gone: Prior studies with similar technologies have demonstrated useful comparisons between new SPECT/CT platforms and standard scanners.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult, who is at least 18 years of age, on day of consent. * Must have a clinically indicated SPECT/CT exam scheduled according to current clinical practice standards; AND * Able and willing to provide informed consent for participation in this study. Exclusion Criteria: * Who, per the site's Standard Operating Procedures (SOPs), has any condition that would prevent the clinically indicated SPECT/CT from proceeding (i.e., pregnancy, breastfeeding, renal impairment, etc.); * Who were previously enrolled in this study; * Who need urgent or emergent care; * Who have any conditions that, in the opinion of the Principal Investigator (PI) or designee, would interfere with the evaluation of the results, or constitute a health hazard for the participant; * Unwilling to have GE Healthcare personnel present during scans; OR * Unable to tolerate the exam.
Where it's running
-
Rambam Health Care Campus
Haifa, Israel Recruiting
Study contacts
- Study coordinator: Erin Terrell, MS
- Email: erin.terrell@gehealthcare.com
- Phone: 1 262 449 3363
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart rate and respiration monitoring device: performance and usability in patients of all ages
We’re testing a new physiological monitor to see how well it works and how easy it is to use for patients from newborns to seniors.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Omni 128 cm PET/CT imaging system: comparing new scanner with standard PET/CT
This study tests a new Omni 128 cm PET/CT scanner by having adults with a planned clinical PET/CT also undergo an extra research scan to compare image quality.
-
Automated Non-Invasive Blood Pressure: Tracking Blood Pressure Changes Using SpO2 Data
This study tests an algorithm that estimates blood pressure changes using data from an SpO2 sensor in patients in the OR, PACU, or ICU who already have invasive BP measured as part of standard care.
-
NIBP Accuracy Validation in Adults
This study tests how accurately a non-invasive blood pressure device measures blood pressure in adults by comparing it with arterial line readings.
-
New Non-Invasive Blood Pressure (NIBP) Enhancement for Neonates and Children
This study tests a new NIBP device enhancement in neonates and kids to see if it can measure blood pressure more accurately.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.